Pharmaceutical ERP: FDA 21 CFR Part 11, Electronic Batch Records & cGMP Compliance
Accelerate batch release times while guaranteeing regulatory audit-readiness. Zero paper batch records, zero transcription errors, and tamper-proof compliance.
Source Integrity Rule: Formal 21 CFR Part 11 software validation package (IQ/OQ/PQ) required per customer deployment [PRODUCT CAPABILITY TO CONFIRM].
Mandatory Regulatory & Quality Standards
Operational Bottlenecks in Pharmaceuticals & Life Sciences
Challenge 01
Multi-week batch release review cycles caused by deciphering paper batch logs
Challenge 02
Deviations and manual signature oversights holding up multimillion-dollar shipments
Challenge 03
Regulatory warning letters from incomplete audit trails or unvalidated changes
End-to-End Shop Floor Execution Workflow
Quarantine & LIMS Release
API materials locked in quarantine until Certificate of Analysis (CoA) parameters pass lab review.
Cleanroom Setup Verification
Line clearance and autoclave sterilization verified with dual-signoff electronic signatures.
Electronic Batch Execution
Operators follow step-by-step digital batch instructions with mandatory dual-witness confirmations.
Batch Review by Exception
QA team reviews only flagged out-of-spec parameters rather than auditing hundreds of pages.
Core Functional Modules for Pharmaceuticals & Life Sciences
Key Industry Performance Indicators (KPIs)
Target KPI 01
Batch Release Cycle Time
Target KPI 02
Deviation Rate %
Target KPI 03
CoA Verification Speed
Target KPI 04
Cleanroom OEE
Frequently Asked Architecture & Compliance Questions
How does Werkora comply with FDA 21 CFR Part 11?
Werkora enforces cryptographic record locking, password/biometric dual-factor signatures, and immutable append-only audit logging [PRODUCT CAPABILITY TO CONFIRM].